Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
MxT Biotech specializes in microfluidic gene editing, utilizing their Hydroporator® platform for the effective delivery of CRISPR-Cas9 RNPs and other genetic materials into primary cells. Their innovative non-viral genome editing technology is pivotal in transforming cancer immunotherapy and cellular engineering.
Reference
Core business
MxT Biotech :: Microfluidics x Therapy
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
Spidercore Inc.
Daejeon, South Korea
A
1-10 Employees
2020
Key takeaway
Spidercore's S.Core platform utilizes a hyper-scale AI engine to analyze nucleotide properties, aiding in the discovery of reliable gene therapies. Their focus on gene-based therapy highlights its potential in treating and preventing diseases, while AI enhances clinical decision-making and patient outcomes.
Reference
Core business
Spidercore Inc.
GENECAST
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
GENECAST specializes in liquid biopsy for early cancer detection, utilizing their innovative ADPS™ technology, which offers exceptional sensitivity of 0.001%. This advanced detection capability enhances cancer management and increases the success rate of targeted therapies.
Reference
Core business
Liquid Biopsy for Cancer Diagnosis - GENECAST
GENECAST specializes in Liquid Biopsy for early detection in Cancer Diagnosis. We have developed ADPS™, a Technology with 0.001% sensitivity ✓ Contact Us.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
GC Genome
Yongin-si, South Korea
A
251-500 Employees
2013
Key takeaway
GC Genome Corporation specializes in clinical genetic testing, which may encompass advancements related to gene editing, particularly in areas like precision oncology and cancer panel testing. Their comprehensive portfolio addresses various unmet needs in genetic health.
Reference
Core business
GC Genome | Clinical Genetic Testing | South Korea
GC Genome | Clinical Genetic Testing | NIPT | Newborn Screening | Cancer Panel | Precision Oncology | Health Checkup
Insilicogen
Yongin-si, South Korea
A
11-50 Employees
2005
Key takeaway
Insilicogen has built a robust bio big data infrastructure over the past 20 years, positioning itself as a leader in bioinformatics solutions.
Reference
Product
Solution | Insilicogen, Inc.
New Era for Bioinformatics
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is at the forefront of research and development, focusing on innovative drug development strategies. Their expertise in dissecting disease microenvironments and combining chemistry with protein engineering positions them to advance multi-target therapies, which could relate to the evolving landscape of gene editing technologies.
Reference
Core business
ONEGENE BIOTECHNOLOGY
BIORCHESTRA
Chungju-si, South Korea
A
1-10 Employees
2016
Key takeaway
BIORCHESTRA focuses on developing innovative RNA medicines and delivery systems that address unmet medical needs, particularly in neurodegenerative and rare diseases of the Central Nervous System. Their best-in-class technology enhances the targeted delivery of RNA therapeutics, offering potential solutions for patients with neglected and incurable conditions.
Reference
Core business
BIORCHESTRA – Innovative RNA Therapeutics
Genuv
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
Genuv is focused on developing treatments for neurodegenerative diseases by promoting neurogenesis and restoring central nervous system (CNS) function. Their innovative approach goes beyond traditional methods, aiming to normalize the immune system and discover substances that enhance neuroprotection.
Reference
Core business
Genuv
Biopharmaceutical company. 신약발굴 플랫폼 기술을 바탕으로 퇴행성 뇌질환, 면역질환, 암질환 등, 난치성 질환분야에서 치료제를 개발하는 연구 중심 신약 개발 기업.
Clecell co.ltd
Seongnam-si, South Korea
A
11-50 Employees
2016
Key takeaway
The company, CLECELL, is innovating in the field of personalized and regenerative medicine through its advanced bioprinting and tissue engineering technologies. Their high-throughput bioprinting platform enables the creation of patient-specific 3D cancer tissues and organoids, which can be used for rapid testing of new and existing chemotherapeutic agents.
Reference
Core business
CLECELL | Biotechnology company | South Korea
CLECELL is trailblazing the field of personalized and regenerative medicine with our revolutionary bioprinting and tissue engineering technology.
Koram Biotech & Koram Biogen Corp
Seoul, South Korea
A
51-100 Employees
1988
Key takeaway
The company, NEB (New England Biolabs), offers GMP-grade products that adhere to strict ISO quality management standards, ensuring high lot-to-lot consistency, which is crucial for reliable gene editing applications.
Reference
Product
ATCC
Technologies which have been searched by others and may be interesting for you:
The Gene Editing industry in South Korea is influenced by several key factors that potential investors and researchers should consider. Regulatory frameworks play a crucial role, as the country has specific laws governing genetic research and application, particularly in human subjects and agricultural products. Understanding these regulations is vital for compliance and successful navigation within the industry. Challenges in this sector include ethical concerns surrounding gene editing technologies, particularly CRISPR, which can raise public apprehension and regulatory scrutiny. However, South Korea offers significant opportunities, especially in healthcare and agriculture, driven by advancements in biotechnology and a strong focus on research and development. The competitive landscape is robust, with numerous startups and established companies actively engaging in gene editing research, often in collaboration with academic institutions. Furthermore, South Korea's strategic position in the global market enhances its relevance, as the country is increasingly recognized for its innovations in biotechnology. Environmental considerations also come into play, particularly regarding the ecological impact of genetically modified organisms. As the industry evolves, stakeholders need to balance technological advancement with sustainability and ethical practices to foster public trust and maintain market growth.
Some interesting numbers and facts about your company results for Gene Editing
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 18 |
| Amount of suitable service providers | 6 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1988 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Gene Editing
What are related technologies to Gene Editing?
Based on our calculations related technologies to Gene Editing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Gene Editing?
Start-Ups who are working in Gene Editing are MxT Biotech
Which industries are mostly working on Gene Editing?
The most represented industries which are working in Gene Editing are Biotechnology, Other, IT, Software and Services, Medical, Pharmaceuticals
How does ensun find these Gene Editing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.